Integrating neuroimaging biomarkers into the multicentre, high-dose erythropoietin for asphyxia and encephalopathy (HEAL) trial: rationale, protocol and harmonisation.
BMJ Open
; 11(4): e043852, 2021 04 22.
Article
in En
| MEDLINE
| ID: mdl-33888528
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Erythropoietin
/
Hypoxia-Ischemia, Brain
Type of study:
Clinical_trials
/
Guideline
Aspects:
Ethics
Limits:
Humans
/
Newborn
Language:
En
Journal:
BMJ Open
Year:
2021
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom